Академический Документы
Профессиональный Документы
Культура Документы
HYPERTENSION
They define and classify HTN as a progressive cardiovascular syndrome with many causes that result in both functional and structural changes to the heart and vascular system .
The new definition incorporates : The presence or absence of risk factors, Early disease markers, Target-organ damage
Abstracts of the 20th Annual Scientific Meeting of the American Society of Hypertension
3% 2
6% 5
Undia gnose d Dia gnose d Controlle d
6 billion people
15 - 20 %
329 %
Hypertensive Normotensive
Controlled Uncontrolled
160
Systolic BP
Blood pressure ( mm Hg )
140
120
100
80
60
DBP
15 - 24 25 - 34 35 - 44 45 - 54 55 - 64 65 - 74 75 - 84 85 - 99
Age ( years )
Epidemiologic data based on the Argentine Blood Pressure study that included a sample of 10,462 noninstitutionalized subjects from 16 Argentine regions. Subjects ranged from 15 to 99 years. BP was measured during a 6-month period by physicians on 2 different days at an interval no greater than 1 week. Galarza et al, Hypertension, 1997.
Hypertension
Hemorrhage stroke LVH, CHD, CHF
CHD = coronary heart disease CHF = congestive heart failure LVH = left ventricular hypertrophy
Retinopathy
Renal failure
Stroke
TARGET ORGAN DISEASE v Risks of CVD at any level of elevated BP are increased several fold for patients with TOD
Manifestations of TOD Cardiac Clinical, electrocardiograph, or radiologic evidence of CAD LVH or strain by ECG or LVH by echo Left ventricular dysfunction or cardiac failure Cereb rovascular TIA or stroke Perip heral vasc ular Absence of 1 or more major pulses in extremities (except dorsalis pedis) with or without intermittent claudication; aneurysm Renal Serum creatinine 1.5 mg/dl Proteinuria (1+ or >) Microalbuminuria EYE Retinopathy Papilledema
CLASSIFICATION
TWO MAIN TYPES. . . Essential hypertension is the most prevalent hypertension type, affecting 90 95% of hypertensive patients. Although no direct cause has been identified, there are many factors such as sedentary lifestyle smoking Stress visceral obesity potassium deficiency obesity (more than 85% of cases occur in those with a body mass index greater than 25) The American Journal of Clinical Nutrition reported in 2005 that waist size was a better predictor of a person's blood pressure than body mass index (BMI). Men should strive for a waist size of 35 inches or under and women 33 inches or under Salt (sodium) sensitivity, Alcohol intake
ESSENTIAL HYPERTENSION.
vitamin D deficiency Risk also increases with aging, some inherited genetic mutations having a family history of hypertension. An elevated level of renin, sympathetic nervous system overactivity. Insulin resistance, which is a component of syndrome X (or the metabolic syndrome), is also thought to contribute to hypertension. Recent studies have implicated low birth weight as a risk factor for adult
SECONDRY HYPERTENSION. Secondary hypertension is high blood pressure that's caused by another medical condition. There are many known conditions that can cause secondary hypertension. Regardless of the cause, arterial pressure becomes elevated either due to an increase in cardiac output, an increase in systemic vascular resistance, or both. When cardiac output is elevated, it is generally due to either increased neurohumoral
OTHER TYPES
MALIGNANT HYPERTENSI0N. Malignant hypertension is a complication of hypertension characterized by very elevated blood pressure, and organ damage in the eyes, brain, heart and/or kidneys. It is considered a hypertensive emergency. Systolic and diastolic blood pressures are usually greater than 200mmHg and 140mmHg, respectively. A diagnosis of malignant hypertension must show papilledema. The disorder affects about 1% of people with high blood
It mostly occurs in people with: Collagen vascular disorders Kidney problems Toxemia of pregnancy Kidney failure Renal hypertension caused by renal artery stenosis RESISTANT HYPERTENSION. Resistant hypertension is defined as blood pressure that remains elevated above treatment goals despite administration of an optimal three drug regimen that includes a diuretic.
CAUSES-- Patient noncompliance with treatment Secondary hypertension (Usually from overactive adrenal glands) Fluid retention (usually expansion from kidney failure). WHITE COAT HYPERTENSI0N.. The phenomenon of high blood pressure which occurs only at the doctor's office is called whitecoat hypertension. Whitecoat hypertension is a result of stress, and will generally fade over time as patients become more adjusted to having their blood pressure checked in the doctor's office. Ambulatory blood pressure monitoring and patient self-measurement using a home blood pressure monitoring device is being increasingly used to differentiate it.
PULMONARY HYPERTENSION..
Pulmonary hypertension is abnormally high blood pressure in the arteries of the lungs. It makes the right side of the heart need to work harder than normal. CAUSES Any condition that causes chronic low oxygen levels in the blood Autoimmune diseases that damage the lungs, such as scleroderma and rheumatoid arthritis Certain birth defects of the heart Certain diet medications Congestive heart failure History of a blood clot in the lung HIV infection Lung or heart valve disease Obstructive sleep apnea Treatment (epoprostenol and Bosentan)
The most recent World Health Organisation (WHO) classification of pulmonary hypertension has it in five types namely pulmonary arterial hypertension, pulmonary venous hypertension, thromboembolic pulmonary hypertension and miscellaneous pulmonary hypertension ISOLATED SYSTOLIC HYPERTENSION. If systolic blood pressure is elevated (>140) with a normal diastolic blood pressure (<90), it is called "isolated systolic hypertension. This disorder primarily affects older people(>60 YEARS) and is characterized by an increased (wide) pulse pressure. ISOLATED DIASTOLIC PRESSURE If arterial stiffness is normal or low even when arteriolar resistance increases, this becomes a case of high diastolic blood pressure. For this cause doctors may use isolated diastolic
Results of a survey by the Third National Health and Nutrition Examination Survey (NHANES) showed that hypertension treatment normalized diastolic blood pressure to <90mm Hg in 89.7% of patients and only to <140mm Hg of systolic pressure in 49.0% of patients.
HYPERTENSION AND PREGNANCY There exist several hypertensive states of pregnancy: Gestational hypertension = usually defined as a BP over 140/90 without the presence of protein in the urine. Preeclampsia = gestational hypertension (BP > 140/90), and proteinuria (>300mg of protein in a 24-hour urine sample). Severe preeclampsia involves a BP over 160/110 (with additional signs) Eclampsia = seizures in a preeclamptic patient HELLP syndrome = Hemolytic anemia, elevated liver enzymes and
EUROPEAN GUIDELINE S
AMERICAN GUIDELINE S
BP goal
< 140 / 90 mmHg < 130 / 80 mmHg < 140 / 90 mmHg < 130 / 80 mmHg < 140 / 90 mmHg < 130 / 80 mmHg
JNC 7
ESH / ESC
WHO / ISH
BP = blood pressure Cardiology JNC = Joint National Committee ESH = European Society of Hypertension Hypertension
ESC = European Society of WHO = World Health Organization ISH = International Society of
BP Measurement Techniques
Method In-office Ambulatory BP monitoring Self-measurement Brief Description Two readings, 5 minutes apart, sitting in chair. Confirm elevated reading in contra Indicated for evaluation of lateral arm. white-coat HTN. Absence of 10 20% BP decrease during sleep may Provides information onrisk. indicate increased CVD response to therapy. May help improve adherence to therapy and evaluate white-coat HTN.
Cigarette smoking Obesity* (BMI >30 kg/m2) Physical inactivity Dyslipidemia Diabetes mellitus Microalbuminuria or estimated GFR <60 ml/min Age (older than 55 for men, 65 for women) Family history of premature CVD (men under age 55 or women under age 65)
Laboratory Tests
Routine Tests Electrocardiogram Urinalysis Blood glucose, and hematocrit Serum potassium, creatinine, or the corresponding estimated GFR, and calcium Lipid profile, after 9- to 12-hour fast, that includes high-density and low-density lipoprotein cholesterol, and triglycerides Optional tests Measurement of urinary albumin excretion or albumin/creatinine ratio More extensive testing for identifiable causes is not generally indicated unless BP control is not achieved
Modification
Weight reduction Adopt DASH eating plan Dietary sodium reduction Physical activity
Benefits of Lowering BP
Average Percent Reduction 3540% infarction 50% Stroke incidence Myocardial 2025% Heart failure
ANTIHYPERTENSIVE DRUGS
Diuretics Adrenergic receptor antagonists Adrenergic receptor agonists Calcium channel blockers Renin Inhibitors ACE inhibitors Angiotensin II receptor antagonists Vasodilators Centrally acting adrenergic drugs
DIURETICS
Diuretics help the kidneys eliminate excess salt and water from the body's tissues and blood.
ALPHA BLOCKERS doxazosin phentolamine indoramin phenoxybenzamine prazosin terazosin Tolazoline Despite lowering blood pressure, alpha blockers have significantly poorer endpoint outcomes than other antihypertensives, and are no longer recommended as a first-line choice in the treatment of hypertension. However, they may be useful for some men with symptoms of prostate disease.
*Update on the Use of Antihypertensive Drugs in Pregnancy Tiina Podymow; Phyllis August (Hypertension. 2008;51:960.) 2008 American Heart Association, Inc.
VASODILATORS
Arterial dilators--Hydralazine Minoxidil Venous dilators--Organic nitrates Molsidomine Mixed dilators--Potassium channel activators Sodium nitroprusside
-18mm Hg
-1 5 -2 0 -2 5 -3 0 -3 5
-32 mm Hg
SBP DBP
Losartan 96%
N = 57
Nefedipine 4%
Leracanidpine 0% Felodipine 1%
-1 0
-18mm Hg
Verapamil 20%
-2 0
-2 5
-3 0
-34 mm Hg
SBP DBP
Diltiazem 5%
Amlodipine 70%
-3 5
N = 391
-1 0
-19mm Hg
Propranolol 2%
Nodalol 0%
-2 0
-2 5
-3 0
-34 mm Hg
Atenolol 86%
SBP DBP
-3 5
N = 640
34 mm Hg
Baseline 166/102 Treated 132/84
18 mm Hg
8 DBP 10 12
(< 140 / 90 mm Hg )
Elderly patients Systolic Heart block* Beta blockers hypertension Angina After MI Tachyarrhythm ias Pregnancy AngiotensinHF converting Left ventricular Hyperkalemia enzyme (ACE) dysfunction Bilateral renal inhibitors After MI artery stenosis Diabetic
HF
Compelling Compelling indications contraindications Angina Heart block Elderly patients Systolic Prostatic hypertension hypertrophy
Pregnancy Hyperkalemia Bilateral renal artery stenosis
nephropathy
THIAZ, ACEI
REFRENCES
Goodman and Gillman 11th edition Evidence-Based Management of Hypertension BY Matthew R. Weir The Dash Diet for Hypertension BY Thomas Moore Rang and Dale's pharmacology 4th edition Katzung Basic and Clinical Pharmacology, 10nth Edition JNC VII REPORT ON HYPERTENSION ESH GUIDELINES 2007 AND 2009 U.S DEPARTMENT OF HEALTH AND HUMAN SERVICES (NATIONAL HEART,LUNG AND BLOOD INSTITUTE RECOMMENDATIONS)
REFRENCES
ARTICLES ISSUED IN CIRCULATION (JOURNAL OF AMERICAN HEART ASSOCIATION) THE LANCET(Volume 376, Issue 9739, Page 415) ARTICLES ISSUED IN HYPERTENSION (JOURNAL OF AMERICAN HEART ASSOCIATION) NOVARTIS LIBRARY WHO/ISH GUIDELINES ON HYPERTENSION (www.who.int/cardiovascular_diseases/gui delines/hypertension/en) www.circ.ahajournals.org www.ash-us.org